Vident Advisory LLC Has $1.78 Million Holdings in Haleon PLC Sponsored ADR $HLN

Key Points

• Vident Advisory LLC significantly increased its holdings in Haleon PLC by 158.3% during Q1, now owning 173,249 shares valued at approximately $1.78 million.
• Haleon recently declared a semi-annual dividend of $0.0555 per share, indicating a yield of 190.0%, an increase from the previous dividend of $0.05.
• Analysts have upgraded Haleon's stock ratings, with new price targets set at an average of $12.33, reflecting a generally positive outlook among equity research analysts.

Vident Advisory LLC increased its holdings in Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 158.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 173,249 shares of the company's stock after acquiring an additional 106,183 shares during the period. Vident Advisory LLC's holdings in Haleon were worth $1,783,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Bartlett & CO. Wealth Management LLC raised its holdings in shares of Haleon by 135.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company's stock worth $27,000 after acquiring an additional 1,491 shares during the last quarter. Opal Wealth Advisors LLC acquired a new stake in shares of Haleon in the 1st quarter worth about $29,000. Deutsche Bank AG raised its holdings in shares of Haleon by 267.8% in the 1st quarter. Deutsche Bank AG now owns 3,126 shares of the company's stock worth $32,000 after acquiring an additional 2,276 shares during the last quarter. Continuum Advisory LLC raised its holdings in shares of Haleon by 152.4% in the 1st quarter. Continuum Advisory LLC now owns 4,753 shares of the company's stock worth $49,000 after acquiring an additional 2,870 shares during the last quarter. Finally, Alpine Bank Wealth Management acquired a new stake in shares of Haleon in the 1st quarter worth about $56,000. Institutional investors and hedge funds own 6.67% of the company's stock.

Haleon Trading Up 1.2%

Shares of HLN stock opened at $9.81 on Tuesday. The company has a 50 day moving average of $9.83 and a 200-day moving average of $10.22. The company has a quick ratio of 0.63, a current ratio of 0.87 and a debt-to-equity ratio of 0.48. Haleon PLC Sponsored ADR has a 12-month low of $8.86 and a 12-month high of $11.42. The firm has a market cap of $43.96 billion, a P/E ratio of 25.14, a PEG ratio of 2.89 and a beta of 0.23.

Haleon Increases Dividend

The business also recently declared a semi-annual dividend, which will be paid on Thursday, September 18th. Stockholders of record on Friday, August 15th will be paid a dividend of $0.0555 per share. This represents a dividend yield of 190.0%. The ex-dividend date is Friday, August 15th. This is an increase from Haleon's previous semi-annual dividend of $0.05. Haleon's dividend payout ratio (DPR) is 28.21%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. BNP Paribas Exane upgraded shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 target price on the stock in a report on Tuesday, May 27th. BNP Paribas upgraded shares of Haleon to a "strong-buy" rating in a research note on Tuesday, May 27th. Morgan Stanley upgraded shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price objective for the company in a research note on Friday, May 9th. Wall Street Zen lowered shares of Haleon from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. Finally, Barclays reiterated an "overweight" rating on shares of Haleon in a research note on Tuesday, May 6th. Two equities research analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $12.33.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon PLC Sponsored ADR (NYSE:HLN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.